Regulatory bodies approved GLP-1 receptor agonists are TRULICITY (dulaglutide), BYETTA/BYDUREON (exenatide), VICTOZA (liraglutide), OZEMPIC/WEGOVY/RYBELSUS, (Semaglutide), MOUNJARO/ZEPBOUND (tirzepatide) and others
PMID: 15246005 Shoubridge CA et al
Global economic burden of diabetes in adults: projections from 2015 to 2030
In that case, the fat cells will be extracted, cleaned, and immediately reinjected in your desired procedure area
While Trulicity does not have FDA approval for weight loss, some prescribers may still prescribe it and see weight loss results in their patients
Kidney function tests, liver enzyme panels, and lipid profiles should be reviewed at baseline and periodically during therapy, since both drug classes can influence metabolic markers